Article

Cutaneous cancer stem cell maintenance is dependent on β-catenin signaling

Ecole Polytechnique Fédérale de Lausanne/ISREC (Swiss Institute for Experimental Cancer Research) and National Center of Competence in Research Molecular Oncology, Chemin des Boveresses 155, 1066 Epalinges, Switzerland.
Nature (Impact Factor: 42.35). 05/2008; 452(7187):650-3. DOI: 10.1038/nature06835
Source: PubMed

ABSTRACT Continuous turnover of epithelia is ensured by the extensive self-renewal capacity of tissue-specific stem cells. Similarly, epithelial tumour maintenance relies on cancer stem cells (CSCs), which co-opt stem cell properties. For most tumours, the cellular origin of these CSCs and regulatory pathways essential for sustaining stemness have not been identified. In murine skin, follicular morphogenesis is driven by bulge stem cells that specifically express CD34. Here we identify a population of cells in early epidermal tumours characterized by phenotypic and functional similarities to normal bulge skin stem cells. This population contains CSCs, which are the only cells with tumour initiation properties. Transplants derived from these CSCs preserve the hierarchical organization of the primary tumour. We describe beta-catenin signalling as being essential in sustaining the CSC phenotype. Ablation of the beta-catenin gene results in the loss of CSCs and complete tumour regression. In addition, we provide evidence for the involvement of increased beta-catenin signalling in malignant human squamous cell carcinomas. Because Wnt/beta-catenin signalling is not essential for normal epidermal homeostasis, such a mechanistic difference may thus be targeted to eliminate CSCs and consequently eradicate squamous cell carcinomas.

Download full-text

Full-text

Available from: Marcel Huber, Aug 20, 2015
1 Follower
 · 
450 Views
  • Source
    • "In addition to the Ras/MAP kinase pathway, the Wnt/b-catenindependent signaling pathway plays an essential role in the development of skin papillomas in mice. The keratinocyte-specific (conditional) knockout of the Ctnnb1 b-catenin gene almost completely prevents papilloma development induced by DMBA/TPA, and the de-activation of the Wnt/b-catenin signaling pathway in pre-existing tumors leads to their complete regression (Malanchi et al., 2008). The same authors demonstrated that human squamous cell carcinomas often contain nuclearly localized b-catenin. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission of the Deutsche Forschungsgemeinschaft) evaluates chemical substances using scientific criteria to prevent adverse effects on health at the work place. As part of this task there is a need to evaluate tumor promoting activity of chemicals (enhancement of formation of squamous cell carcinomas via premalignant papillomas) obtained from two-stage initiation/promotion experiments using the mouse skin model. In the present communication we address this issue by comparing responses seen in mouse skin with those in humans. We conclude that tumor promotional effects seen in such animal models be carefully analyzed on a case by case basis. Substances that elicit a rather non-specific effect that is restricted to the high dose range are considered to be irrelevant to humans and thus do not require classification as carcinogens. In contrast, substances that might have both a mode of action and a potency similar to the specific effects seen with TPA (12-O-tetradecanoylphorbol-13-acetate), the prototype tumor promoter in mouse skin, which triggers receptor-mediated signal cascades in the very low dose range, have to be classified in a category for carcinogens. Copyright © 2015. Published by Elsevier Inc.
    Regulatory Toxicology and Pharmacology 04/2015; 72(1). DOI:10.1016/j.yrtph.2015.03.014 · 2.14 Impact Factor
  • Source
    • "Here, we report that mice with increased Wnt/b-catenin and attenuated Bmp signalling in Keratin 14-expressing tissues rapidly develop salivary gland SCC, from which we can enrich tumour propagating cells by FACS. The importance of canonical Wnt signalling in tumour propagating cells is known (Malanchi et al, 2008; Barker et al, 2009; Wend et al, 2010). We provide evidence that b-catenin activation leads to an induction and stabilization of MLL, and that b-catenin, CBP and MLL are required to trigger H3K4 tri-methylation at promoters of self-renewal genes in tumour propagating cells (summary scheme in Figure 7A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We show that activation of Wnt/β-catenin and attenuation of Bmp signals, by combined gain- and loss-of-function mutations of β-catenin and Bmpr1a, respectively, results in rapidly growing, aggressive squamous cell carcinomas (SCC) in the salivary glands of mice. Tumours contain transplantable and hyperproliferative tumour propagating cells, which can be enriched by fluorescence activated cell sorting (FACS). Single mutations stimulate stem cells, but tumours are not formed. We show that β-catenin, CBP and Mll promote self-renewal and H3K4 tri-methylation in tumour propagating cells. Blocking β-catenin-CBP interaction with the small molecule ICG-001 and small-interfering RNAs against β-catenin, CBP or Mll abrogate hyperproliferation and H3K4 tri-methylation, and induce differentiation of cultured tumour propagating cells into acini-like structures. ICG-001 decreases H3K4me3 at promoters of stem cell-associated genes in vitro and reduces tumour growth in vivo. Remarkably, high Wnt/β-catenin and low Bmp signalling also characterize human salivary gland SCC and head and neck SCC in general. Our work defines mechanisms by which β-catenin signals remodel chromatin and control induction and maintenance of tumour propagating cells. Further, it supports new strategies for the therapy of solid tumours.
    The EMBO Journal 06/2013; 32(14). DOI:10.1038/emboj.2013.127 · 10.75 Impact Factor
  • Source
    • "The cell proliferation marker, Ki67, was frequently expressed in the skin cancer cells, but the HA/Ptch positive cells (78–100%) were largely negative for Ki67 expression (Figure 6b), indicating that these cells are likely non-proliferative. We also performed co-staining of the known skin stem cell markers, Sox2, Pax6, or Cd34, with the HA/Ptch tag (Takahashi, 2008; Li, 2005; Malanchi et al., 2008). Some HA/Ptch positive cells showed co-staining with Sox2 and Pax6, but the pattern was essentially random (Figure 6c), and these cells were largely negative for Cd34 (Figure 6c). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ptch1 is a key regulator of embryonic development, acting through the sonic hedgehog (SHH) signaling pathway. Ptch1 is best known as a tumor suppressor, as germline or somatic mutations in Ptch1 lead to the formation of skin basal cell carcinomas. Here we show that Ptch1 also acts as a lineage-dependent oncogene, as overexpression of Ptch1 in adult skin in K14Ptch(FVB) transgenic mice synergizes with chemically induced Hras mutations to promote squamous carcinoma development. These effects were not because of aberrant activation of SHH signaling by the K14Ptch(FVB) transgene, as developmental defects in the highest expressing transgenic lines were consistent with the inhibition of this pathway. Carcinomas from K14Ptch(FVB) transgenic mice had only a small number of nonproliferative Ptch1 transgene-positive cells, suggesting that the Ptch1 transgene is not required for tumor maintenance, but may have a critical role in cell-fate determination at the initiation stage.Journal of Investigative Dermatology advance online publication, 6 December 2012; doi:10.1038/jid.2012.419.
    Journal of Investigative Dermatology 12/2012; 133(5). DOI:10.1038/jid.2012.419 · 6.37 Impact Factor
Show more